BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7928670)

  • 1. MS-282a and MS-282b, new inhibitors of calmodulin-activated myosin light chain kinase from Streptomyces tauricus ATCC 27470.
    Nakanishi S; Kita K; Uosaki Y; Yoshida M; Saitoh Y; Mihara A; Kawamoto I; Matsuda Y
    J Antibiot (Tokyo); 1994 Aug; 47(8):855-61. PubMed ID: 7928670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MS-271, a novel inhibitor of calmodulin-activated myosin light chain kinase from Streptomyces sp.--I. Isolation, structural determination and biological properties of MS-271.
    Yano K; Toki S; Nakanishi S; Ochiai K; Ando K; Yoshida M; Matsuda Y; Yamasaki M
    Bioorg Med Chem; 1996 Jan; 4(1):115-20. PubMed ID: 8689231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MS-347a, a new inhibitor of myosin light chain kinase from Aspergillus sp. KY52178.
    Nakanishi S; Ando K; Kawamoto I; Matsuda Y
    J Antibiot (Tokyo); 1993 Dec; 46(12):1775-81. PubMed ID: 8294233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanism of inhibition of light-chain phosphorylation by purealin in chicken gizzard myosin.
    Takito J; Ohizumi Y; Nakamura H; Kobayashi J; Ebisawa K; Nonomura Y
    Eur J Pharmacol; 1987 Oct; 142(2):189-95. PubMed ID: 2961581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of felodipine (a dihydropyridine calcium channel blocker) and analogues on calmodulin-dependent enzymes.
    Walsh MP; Sutherland C; Scott-Woo GC
    Biochem Pharmacol; 1988 Apr; 37(8):1569-80. PubMed ID: 2833901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MS-444, a new inhibitor of myosin light chain kinase from Micromonospora sp. KY7123.
    Nakanishi S; Chiba S; Yano H; Kawamoto I; Matsuda Y
    J Antibiot (Tokyo); 1995 Sep; 48(9):948-51. PubMed ID: 7592060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificities of autoinhibitory domain peptides for four protein kinases. Implications for intact cell studies of protein kinase function.
    Smith MK; Colbran RJ; Soderling TR
    J Biol Chem; 1990 Feb; 265(4):1837-40. PubMed ID: 2153665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective calmodulin inhibition toward myosin light chain kinase by a new cerebral circulation improver, Ro 22-4839.
    Nakajima T; Katoh A
    Mol Pharmacol; 1987 Jul; 32(1):140-6. PubMed ID: 3037298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential inhibition of cyclic AMP-dependent protein kinase, myosin light chain kinase and protein kinase C by azaacridine and acridine derivatives.
    Chen Q; Deady LW; Polya GM
    Biol Chem Hoppe Seyler; 1994 Apr; 375(4):223-35. PubMed ID: 8060530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of calmodulin-activated smooth-muscle myosin light-chain kinase by calmodulin-binding peptides and fluorescent (phosphodiesterase-activating) calmodulin derivatives.
    Török K; Cowley DJ; Brandmeier BD; Howell S; Aitken A; Trentham DR
    Biochemistry; 1998 Apr; 37(17):6188-98. PubMed ID: 9558358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of myosin light chain kinase inhibitors from microorganisms: dehydroaltenusin, altenusin, atrovenetinone, and cyclooctasulfur.
    Nakanishi S; Toki S; Saitoh Y; Tsukuda E; Kawahara K; Ando K; Matsuda Y
    Biosci Biotechnol Biochem; 1995 Jul; 59(7):1333-5. PubMed ID: 7670197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent peptide inhibitors of smooth muscle myosin light chain kinase: mapping of the pseudosubstrate and calmodulin binding domains.
    Foster CJ; Johnston SA; Sunday B; Gaeta FC
    Arch Biochem Biophys; 1990 Aug; 280(2):397-404. PubMed ID: 2369131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wortmannin, a microbial product inhibitor of myosin light chain kinase.
    Nakanishi S; Kakita S; Takahashi I; Kawahara K; Tsukuda E; Sano T; Yamada K; Yoshida M; Kase H; Matsuda Y
    J Biol Chem; 1992 Feb; 267(4):2157-63. PubMed ID: 1733924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and characterization of myosin light-chain kinase from the rat pancreas.
    Bissonnette M; Kuhn D; de Lanerolle P
    Biochem J; 1989 Mar; 258(3):739-47. PubMed ID: 2730565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mode of inhibition of smooth muscle myosin light chain kinase by synthetic peptide analogs of the regulatory site.
    Ikebe M
    Biochem Biophys Res Commun; 1990 Apr; 168(2):714-20. PubMed ID: 2334433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of phosphorylated myosin light chain kinase on the ATP-dependent actin-myosin interaction.
    Samizo K; Okagaki T; Kohama K
    Biochem Biophys Res Commun; 1999 Jul; 261(1):95-9. PubMed ID: 10405329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of myosin light chain kinase, cAMP-dependent protein kinase, protein kinase C and of plant Ca(2+)-dependent protein kinase by anthraquinones.
    Jinsart W; Ternai B; Polya GM
    Biol Chem Hoppe Seyler; 1992 Sep; 373(9):903-10. PubMed ID: 1466788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of signal-regulated protein kinases by plant-derived hydrolysable tannins.
    Polya GM; Wang BH; Foo LY
    Phytochemistry; 1995 Jan; 38(2):307-14. PubMed ID: 7772301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of caldesmon isolated from chicken gizzard.
    Ngai PK; Walsh MP
    Biochem J; 1985 Sep; 230(3):695-707. PubMed ID: 2998332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of calmodulin in the first calcium-binding pocket by myosin light chain kinase.
    Davis HW; Crimmins DL; Thoma RS; Garcia JG
    Arch Biochem Biophys; 1996 Aug; 332(1):101-9. PubMed ID: 8806714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.